搜尋
市場行情
自選股
新聞
分析
交易工具
選股工具
掃碼下載
一鍵診股 讓投資更聰明
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
登入
免費註冊
搜尋
免費註冊
市場行情
/
股票
/
醫藥與醫學研究
/
生物技術與醫療研究
/
rxrx
/
財務摘要
Recursion Pharmaceuticals Inc
RXRX
添加自選
3.200
USD
+0.040
+1.27%
收盤 09-11 16:00(美東)
1.70B
總市值
虧損
本益比TTM
盤後交易 18:44 (美東)
3.200
USD
+0.010
+0.31%
Recursion Pharmaceuticals Inc
3.200
+0.040
+1.27%
概覽
新聞分析
財務
股票評分
技術分析
預測
持股情況
股息
公司資料
財務摘要
利潤表
資產負債表
現金流量表
公司收入
財報
公司估值
風險評估
概覽
新聞分析
財務
股票評分
技術分析
預測
持股情況
股息
公司資料
財務摘要
利潤表
資產負債表
現金流量表
公司收入
財報
公司估值
風險評估
RXRX 財務數據
透過專為投資者打造的一站式數據看板,全面查看 Recursion Pharmaceuticals Inc 的財務狀況。平台將複雜的財務報表整理為可自定義的視圖,助您更輕鬆地進行財務分析。您可以查看最新年度財務報告,也可以通過利潤表、資產負債表和現金流量表,按季度分析公司表現。借助實時財務指標,持續追蹤公司的經營狀況和市場表現更加便捷。
關鍵財務比率
總市值
1.70B
股利TTM
0.00
本益比TTM
-2.75
每股盈餘TTM
-1.16
營業收入
74.68M
淨利潤
-463.66M
淨資產收益率
-57.16%
總資產收益率
-42.33%
Recursion Pharmaceuticals Inc 財報行事曆
最新發布
8月 5, 2026
每股收益 / 預測值
-0.25
/-0.23
營業收入 / 預測值
7.67M
/11.95M
財務報表摘要
單季報
單季報+年報
單季報
年報
YOY
隱藏空白列
FY2026Q2
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
財務指標
每股收益
40.26%
-0.25
55.84%
-0.22
61.03%
-0.21
-7.03%
-0.36
-2.27%
-0.41
-29.86%
-0.50
-31.70%
-0.53
22.46%
-0.34
-3.17%
-0.40
-13.56%
-0.39
-30.45%
-0.40
--
-0.44
--
-0.39
--
-0.34
--
-0.31
--
-1.06
--
--
--
--
--
--
--
--
營業收入
-60.10%
7.67M
-56.11%
6.47M
681.74%
35.54M
-80.16%
5.17M
33.34%
19.22M
6.89%
14.74M
-58.26%
4.55M
147.62%
26.08M
30.86%
14.42M
13.68%
13.79M
-20.36%
10.89M
-19.96%
10.53M
43.56%
11.02M
127.53%
12.13M
439.91%
13.68M
419.34%
13.16M
201.06%
7.67M
108.16%
5.33M
--
2.53M
--
2.53M
淨利潤
23.79%
-131.00M
41.97%
-117.50M
39.56%
-108.12M
-69.29%
-162.25M
-76.23%
-171.90M
-121.60%
-202.49M
-92.38%
-178.91M
-3.04%
-95.84M
-27.13%
-97.54M
-39.87%
-91.37M
-61.75%
-93.00M
-53.89%
-93.02M
-17.03%
-76.73M
-16.70%
-65.33M
11.46%
-57.49M
-27.45%
-60.45M
-51.06%
-65.56M
-82.24%
-55.98M
--
-64.93M
--
-47.43M
利潤率
-91.01%
-1708.02%
-32.21%
-1815.57%
92.27%
-304.24%
-753.23%
-3135.32%
-32.17%
-894.23%
-107.31%
-1373.26%
-360.89%
-3935.46%
58.39%
-367.46%
2.85%
-676.56%
-23.04%
-662.41%
-103.12%
-853.88%
--
-883.10%
--
-696.43%
--
-538.38%
--
-420.39%
--
-695.47%
--
--
--
--
--
--
--
--
毛利率
-920.94%
-49.82%
-93.54%
-92.99%
132.98%
59.83%
-442.36%
-183.81%
-113.48%
-4.88%
-352.17%
-48.04%
-2056.44%
-181.43%
1743.89%
53.69%
143.88%
36.19%
836.22%
19.05%
-55.28%
9.27%
--
-3.27%
--
14.84%
--
-2.59%
--
20.74%
--
-43.06%
--
--
--
--
--
--
--
--
資產負債率
-33.56%
1.17%
-35.98%
1.23%
-33.21%
1.27%
-62.38%
1.49%
-55.94%
1.76%
850.16%
1.92%
984.56%
1.89%
1269.88%
3.95%
1356.24%
4.00%
-31.18%
0.20%
93.55%
0.17%
--
0.29%
--
0.27%
--
0.29%
--
0.09%
--
0.11%
--
--
--
--
--
--
--
--
利潤表
營業收入
-60.10%
7.67M
-56.11%
6.47M
681.74%
35.54M
-80.16%
5.17M
33.34%
19.22M
6.89%
14.74M
-58.26%
4.55M
147.62%
26.08M
30.86%
14.42M
13.68%
13.79M
-20.36%
10.89M
-19.96%
10.53M
43.56%
11.02M
127.53%
12.13M
439.91%
13.68M
419.34%
13.16M
201.06%
7.67M
108.16%
5.33M
--
2.53M
--
2.53M
營業利潤
23.41%
-134.97M
32.85%
-128.50M
41.05%
-108.33M
-75.08%
-172.20M
-75.28%
-176.23M
-98.64%
-191.37M
-85.76%
-183.77M
1.20%
-98.35M
-23.04%
-100.54M
-40.30%
-96.34M
-62.23%
-98.93M
-59.09%
-99.55M
-28.91%
-81.72M
-22.66%
-68.67M
6.12%
-60.98M
-34.85%
-62.57M
-54.88%
-63.39M
-83.64%
-55.98M
--
-64.96M
--
-46.40M
淨利潤
23.79%
-131.00M
41.97%
-117.50M
39.56%
-108.12M
-69.29%
-162.25M
-76.23%
-171.90M
-121.60%
-202.49M
-92.38%
-178.91M
-3.04%
-95.84M
-27.13%
-97.54M
-39.87%
-91.37M
-61.75%
-93.00M
-53.89%
-93.02M
-17.03%
-76.73M
-16.70%
-65.33M
11.46%
-57.49M
-27.45%
-60.45M
-51.06%
-65.56M
-82.24%
-55.98M
--
-64.93M
--
-47.43M
資產負債表
流動資產
2.78%
603.46M
21.47%
709.56M
13.80%
812.85M
50.60%
714.11M
12.40%
587.16M
70.00%
584.14M
63.02%
714.27M
15.50%
474.17M
21.20%
522.38M
-30.18%
343.62M
-23.11%
438.14M
-14.76%
410.52M
-21.06%
431.02M
-20.56%
492.13M
6.56%
569.81M
-19.85%
481.62M
-15.69%
546.00M
179.26%
619.46M
--
534.72M
--
600.87M
流動負債總額
-26.91%
119.89M
-8.65%
129.70M
-21.21%
147.71M
42.44%
155.10M
90.54%
164.03M
92.07%
141.98M
101.21%
187.47M
15.69%
108.89M
-24.46%
86.08M
-19.78%
73.92M
-7.08%
93.17M
13.35%
94.12M
17.91%
113.96M
7.52%
92.15M
114.89%
100.27M
93.36%
83.04M
227.19%
96.65M
219.15%
85.70M
--
46.66M
--
42.94M
總資產
-6.89%
1.21B
2.63%
1.34B
1.76%
1.47B
92.64%
1.40B
67.86%
1.30B
133.98%
1.31B
121.60%
1.45B
15.17%
726.50M
16.37%
775.86M
-11.08%
557.85M
-6.79%
653.70M
3.15%
630.83M
-0.86%
666.70M
-14.56%
627.37M
14.90%
701.29M
-7.15%
611.53M
-3.73%
672.51M
170.03%
734.32M
--
610.35M
--
658.61M
總負債
-22.32%
297.67M
-15.23%
314.75M
-17.05%
343.26M
74.60%
352.58M
100.20%
383.21M
136.95%
371.29M
117.50%
413.82M
4.71%
201.94M
-3.20%
191.41M
-20.54%
156.70M
-11.70%
190.26M
-13.71%
192.86M
-15.83%
197.74M
-18.09%
197.19M
219.67%
215.48M
275.16%
223.50M
320.46%
234.94M
324.89%
240.75M
--
67.41M
--
59.57M
總權益
-0.45%
915.00M
9.72%
1.02B
9.29%
1.13B
99.59%
1.05B
57.27%
919.15M
132.82%
933.95M
123.28%
1.03B
19.77%
524.56M
24.63%
584.45M
-6.75%
401.15M
-4.60%
463.44M
12.87%
437.97M
7.17%
468.96M
-12.84%
430.18M
-10.52%
485.81M
-35.22%
388.03M
-31.92%
437.58M
129.27%
493.57M
--
542.94M
--
599.03M
現金流量表
經營淨額
-38.64%
-105.95M
38.54%
-81.10M
60.09%
-46.07M
-98.16%
-117.36M
7.06%
-76.42M
-28.99%
-131.96M
-55.82%
-115.43M
18.78%
-59.23M
-21.87%
-82.22M
-39.53%
-102.30M
-65.54%
-74.08M
-33.70%
-72.92M
-9.48%
-67.47M
-194.74%
-73.32M
26.83%
-44.75M
-65.04%
-54.54M
-83.11%
-61.62M
351.63%
77.39M
--
-61.16M
--
-33.05M
投資淨額
66.27%
-1.96M
95.35%
-338.00K
-100.45%
-1.24M
44.13%
-2.55M
-38.88%
-5.81M
-9.27%
-7.27M
11171.38%
275.46M
-1214.70%
-4.56M
-103.70%
-4.18M
-24.59%
-6.65M
68.82%
-2.49M
-100.65%
-347.00K
-141.56%
-2.05M
-103.73%
-5.34M
84.73%
-7.98M
127.33%
52.98M
179.52%
4.94M
838.07%
143.30M
--
-52.24M
--
-193.87M
融資淨額
-101.30%
-1.27M
-108.56%
-3.47M
1140.77%
132.01M
1426.79%
251.34M
-62.88%
97.66M
191.62%
40.53M
-86.81%
10.64M
-69.38%
16.46M
6848.03%
263.12M
623.05%
13.90M
-45.23%
80.66M
2200.60%
53.77M
41.94%
3.79M
-7.77%
1.92M
3779.24%
147.26M
121.06%
2.34M
-99.42%
2.67M
-2.34%
2.08M
--
3.80M
--
-11.10M
營業收入
業務
報告期:
暫無數據
地區
報告期:
暫無數據
常見問題
Recursion Pharmaceuticals Inc的總收入是多少?
根據Recursion Pharmaceuticals Inc的FY2025財報,總收入達到74.68M(同比變化58.84M)。
Recursion Pharmaceuticals Inc的流動資產是多少?
根據Recursion Pharmaceuticals Inc的FY2025財報,流動資產為812.85M(同比變化13.80)。
Recursion Pharmaceuticals Inc的總資產是多少?
根據Recursion Pharmaceuticals Inc的FY2025財報,Recursion Pharmaceuticals Inc的總資產為1.47B(同比變化1.76)。
Recursion Pharmaceuticals Inc的總負債是多少?
根據Recursion Pharmaceuticals Inc的FY2025財報,Recursion Pharmaceuticals Inc的總責任為343.26M(同比變化-17.05)。
Recursion Pharmaceuticals Inc的總權益是多少?
根據Recursion Pharmaceuticals Inc的FY2025財報,Recursion Pharmaceuticals Inc的總權益為1.13B(同比變化9.29)。
Recursion Pharmaceuticals Inc的淨營業收入是多少?
根據Recursion Pharmaceuticals Inc的FY2025財報,Recursion Pharmaceuticals Inc的淨營業收入為-648.13M(同比變化-35.31)。
Recursion Pharmaceuticals Inc的淨投資是多少?
根據Recursion Pharmaceuticals Inc的FY2025財報,Recursion Pharmaceuticals Inc的淨投資為-16.87M(同比變化-106.49)。
Recursion Pharmaceuticals Inc的淨融資是多少?
根據Recursion Pharmaceuticals Inc的FY2025財報,Recursion Pharmaceuticals Inc的淨融資為521.53M(同比變化71.49)。
Recursion Pharmaceuticals Inc的每股收益(EPS)是多少?
根據Recursion Pharmaceuticals Inc的FY2025財報,每股收益(EPS)為-1.44(同比變化14.78)。
Recursion Pharmaceuticals Inc的淨利潤是多少?
根據Recursion Pharmaceuticals Inc的FY2025財報,淨利潤為-644.76M(同比變化-39.06)。
Recursion Pharmaceuticals Inc的淨利潤率是多少?
根據Recursion Pharmaceuticals Inc的FY2025財報,淨利潤率為-863.35(同比變化-9.56)。
Recursion Pharmaceuticals Inc的毛利率是多少?
根據Recursion Pharmaceuticals Inc的FY2025財報,毛利率為4.99(同比變化-78.40)。
Recursion Pharmaceuticals Inc的債務與資產比率是多少?
根據Recursion Pharmaceuticals Inc的FY2025財報,債務與資產比率為1.27(同比變化-33.21)。
Recursion Pharmaceuticals Inc的股東權益回報率(ROE)是多少?
根據Recursion Pharmaceuticals Inc的FY2025財報,股東權益回報率(ROE)為-59.54(同比變化3.80)。
Recursion Pharmaceuticals Inc的資產回報率(ROA)是多少?
根據Recursion Pharmaceuticals Inc的FY2025財報,資產回報率(ROA)為-44.12(同比變化-0.02)。
Recursion Pharmaceuticals Inc的營業利潤是多少?
根據Recursion Pharmaceuticals Inc的FY2025財報,營業利潤為-648.13M(同比變化-35.31)。